ABSTRACT
ABSTRACT For athletes under training, it is more efficient to use the Internet of Things (IoT) and cloud computing methods to collect and process biochemical indicators, and this study is about research based on the IoT and cloud computing technology for athletes under training. The problems are put forward in this study. The requirements of related algorithm design and the communication model properties are comprehensively analyzed. Scheduling the link and allocating the transmit power of the nodes are comprehensively considered, with design and analysis of wireless sensor network scheduling algorithm. The factors influencing the scheduling efficiency of the algorithm are analyzed, considering the node density and the influence of different power allocation schemes on the scheduling result. This study shows that the algorithm of this thesis can collect the biochemical index data of athletes during training period. As the number of nodes increases, the running results will gradually move towards the optimal value. This research study is of important theoretical significance for the application of IoT and cloud computing technology and the improvement of athlete training effect.
RESUMO Para os indicadores bioquímicos dos atletas durante o treino, é mais eficiente usar a internet das coisas e métodos de computação em nuvem para coletar e processar indicadores bioquímicos durante o treino de atletas. Este estudo se baseia na tecnologia da internet das coisas IoT e na computação em nuvem voltada para atletas durante o período de treino. Os problemas são apresentados neste documento. Os requisitos de concepção de algoritmos relacionados e propriedades do modelo de comunicação são amplamente analisados. A programação do link e a alocação da potência de transmissão dos nodos são considerados de forma abrangente, com projeto e análise do algoritmo de programação da rede de sensores sem fio. Os fatores que influenciam a eficiência de programação do algoritmo são analisados, considerando a densidade do nodo e a influência de diferentes sistemas de alocação de energia no resultado da programação. A pesquisa Mostra que o algoritmo desta tese pode coletar os dados do índice bioquímico dos atletas durante o período de treino. À medida que o número de nodos aumenta, os resultados de execução tenderão gradualmente para o valor ideal. Esta pesquisa tem um significado teórico importante para a aplicação da tecnologia da internet das coisas e computação em nuvem e para a melhoria do efeito dos treinos realizados por atletas.
RESUMEN Para los indicadores bioquímicos de los atletas durante el entrenamiento, es más eficiente usar la internet de las cosas y métodos de computación en nube para recolectar y procesar indicadores bioquímicos durante el entrenamiento de atletas. Este estudio se basa en la tecnología de la internet de las cosas IoT y en la computación en nube dedicada a atletas durante el período de entrenamiento. Los problemas son presentados en este documento. Los requisitos de concepción de algoritmos relacionados y propriedades del modelo de comunicación son ampliamente analizados. La programación del link y la destinación de la potencia de transmisión de los nodos son considerados de forma abarcadora, con proyecto y análisis del algoritmo de programación de la red de sensores inalámbrica. Los fatores que influencian la eficiencia de programación del algoritmo son analizados, considerando la densidad del nodo y la influencia de diferentes sistemas de destinación de energía en el resultado de la programación. La investigación muestra que el algoritmo de esta tesis puede recolectar los datos del índice bioquímico de los atletas durante el período de entrenamiento. A medida que el número de nodos aumenta, los resultados de ejecución tenderán gradualmente hacia el valor ideal. Esta investigación tiene un significado teórico importante para la aplicación de la tecnología de la internet de las cosas y computación en nube y para la mejora del efecto de los entrenamientos realizados por atletas.
Subject(s)
Humans , Biochemical Phenomena , Computer Systems , Athletic Performance , Athletes , AlgorithmsABSTRACT
OBJECTIVE: This study aims to investigate whether there are any notable etiologies for repeated biochemical pregnancy (RBP) and, if so, to compare those etiologies associated with repeated spontaneous abortion in infertile couples who have undergone in vitro fertilization (IVF). METHODS: Forty-four infertile couples who underwent IVF and experienced RBP were included in this study. RBP was defined as more than 2 early pregnancy losses that occurred before the detection of a gestational sac, with ectopic pregnancies specifically excluded by serial serum beta human chorionic gonadotropin evaluation. Forty-three infertile couples who underwent IVF and experienced recurrent spontaneous abortion (RSA) were included as a control group. Karyotype analysis, anatomic evaluation of uterus, endocrine and immunological evaluation were performed. In addition, the number of pregnant women confirmed by 12 weeks' gestation was compared between groups. RESULTS: Immunological factors (RSA: 20.9% vs. RBP: 29.5%, P=0.361), diminished ovarian reserve (RSA: 10.9% vs. RBP: 17%, P=0.552), and parental chromosomal abnormalities (RSA: 18.6% vs. RBP: 9.1%, P=0.218) were not different between groups. Additionally, the incidence of uterine factors (RSA: 11.6% vs. RBP: 4.6%, P=0.206), unknown cause (RSA: 48.8% vs. RBP: 54.5%, P=0.161), and the pregnancy outcome identified until 12 weeks' gestation (RSA: 46.5% vs. RBP: 38.6%, P=0.520) did not differ between groups. CONCLUSION: In the present study, the causes of RBP after IVF were similar to those of RSA. Accordingly, we suggest that efforts should be made to define the etiology of RBP, particularly for infertile couples, and that possible management strategies should be offered.
Subject(s)
Female , Humans , Pregnancy , Abortion, Habitual , Abortion, Spontaneous , Biochemical Phenomena , Chorionic Gonadotropin , Chromosome Aberrations , Family Characteristics , Fertilization in Vitro , Gestational Sac , Immunologic Factors , In Vitro Techniques , Incidence , Karyotype , Ovarian Reserve , Parents , Pregnancy Outcome , Pregnancy, Ectopic , Pregnant Women , UterusABSTRACT
Objective To investigate the serum levels of biochemical indexes such as calcium,phosphorus,iron,zinc,and alkaline phosphatase of children in Kaschin-Beck disease areas and control areas in Qinghai Province.Methods According to the results of Kaschin-Beck disease monitoring in Qinghai Province,Tangnaihai Township of Xinghai County and Gandu Town of Hualong County were chosen as Kaschin-Beck disease areas and Qushian Township of Xinghai Country was chosen as a control.Children aged 7 to 15 in boarding schools in these areas were chosen as the study subjects in June 2014.Serum alkaline phosphatase level was determined by enzyme colorimetry and the serum iron,zinc,calcium and phosphorus levels were determined by colorimetry.Calcium to phosphate ratio was calculated at the same time.Results Fifty-nine qualified serum samples of children were sampled in Kaschin-Beck disease areas and 45 in control area.Serum alkaline phosphatase levels in Kaschin-Beck disease areas and control area were (311.34 ± 85.31) and (264.09 ± 73.44)U/L,respectively,and the difference was statistically significant (t =-2.97,P ＜ 0.05).Children's serum phosphorus levels in Kaschin-Beck disease areas and control area were (1.62 ± 0.17) and (1.43 ± 0.13)mmol/L,respectively,and the difference was statistically significant (t =-6.29,P ＜ 0.05).Calcium to phosphorus ratio were 1.62 ± 0.17 and 1.82 ± 0.21,respectively,and the difference was statistically significant (t =5.53,P ＜ 0.05).Compared with the control area,the level of children's serum zinc was (19.96 ± 1.70) and (20.59 ± 2.45)μmol/L;the level of serum calcium was (2.59 ± 0.11) and (2.57 ± 0.11)mmol/L;and the level of serum iron was (15.06 ± 7.02) and (17.01 ± 6.70)μmol/L.The differences between these three biochemical indicators were not statistically significant between Kaschin-Beck disease areas and control area (t =1.39,-0.64,1.44,all P ＞ 0.05).Conclusion In Kaschin-Beck disease areas in Qinghai Province,the level of children's serum alkaline phosphatase and phosphorus have increased markedly and the calcium to phosphate ratio has decreased obviously.
ABSTRACT
Objective To observe the biochemical indicators and lifestyles of patients with non-alcoholic fatty liver disease (NAFLD),and analyse the risk factors of induced NAFLD.Methods A total of 258 in-and out-patients of NAFLD were included in the present study,the control group consisted of 213 examinationers with nonfatty liver disease.All samples were being blood biochemical indicator detection and lifestyle survey.Results Some blood biochemical index of NAFLD patients such as TC(5.48 ± 1.10) mmol/L,TG(2.31 ± 1.25) mmol/L,ALT (51.35 ± 26.18) U/L,AST (42.37 ± 28.32) U/L,FPG (5.62 ± 3.24) mmol/L,GGT (58.47 ± 43.25) U/L and UA (398.51 ± 96.85) μmol/L were higher than those of the control group (t =3.423,5.250,7.402,4.348,3.326,6.683,3.891,all P ＜ 0.01) ; and the incidence of hyperlipidemia,hypertension (21.71％),diabetes (22.09％),BMI(26.85 ± 3.45) or metabolic syndrome (44.57％) etc.Those indexes in NAFLD patients were significantly higher than those in the control group (x2 =8.14,10.55,58.48,t =10.73,all P ＜ 0.01).By multivariable Logistic regression analysis,TG,WI,BMI,HOMA-IR,lack of exercise,high-fat diet were independent risk factors for NAFLD (all P ＜ 0.05).Conclusion Patients with NAFLD is closely correlated to metabolic abnormalities,reasonable diet and a healthy lifestyle is an effective way of prevention and treatment of this disease.
ABSTRACT
Objective: To identify and analyze the presence of antinutritional factors in possible interactions between medications and foods/nutrients of the diets prescribed for patients of the Hospital Regional Justino Luz, in the city of Picos (PI) in order to suggest their likely mechanisms. Methods: The sample was made up of 120 medical records of hospitalized patients. The charts were analyzed to verify the presence or absence of interactions between medications and foods/nutrients of the diets prescribed to the patients at the Hospital Regional Justino Luz, emphasizing the action of antinutritional factors in these interactions. Results: Of the 189 medications prescribed, 128 (67.7%) had a possible interaction with food, totaling up 98 possible interactions between nutrients/foods and medications. Therefore, 20 (20.4%), 12 (12.2%) and 11 (11.2%) possible interactions were identified with captopril, acetylsalicylic acid and spironolactone, respectively, representing, in this order, the greatest frequencies of possible interactions among drugs and foods. A total of nine antinutritional factors were found in seven vegetable foods prescribed to inpatients, in which five (55.6%) were capable of interacting with the medications. Phytates and tannins had the largest quantity of possible interactions with drugs, each with 4 (26.7%) in a total of 15 interactions. The medications aluminum hydroxide, digoxin, and paracetamol attained greater probability of interaction with antinutrients, with 5 (33.3%), 3 (20%) and 3 (20%) interactions, respectively. Conclusion: Due to the large quantity of antinutritional factors capable of interacting with drugs prescribed for inpatients, the involvement of a multiprofessional team is indispensable so that these possible interactions between foods, antinutritional factors and drugs might be foreseen, detected, and resolved.
Subject(s)
Biochemical Phenomena , Food , Food-Drug Interactions , Pharmaceutical PreparationsABSTRACT
Objective: To evaluate the prescription in relation to the possible interactions between drugs and foods/nutrients of the diets of patients in the Hospital Regional Justino Luz in the municipality of Picos, Piauí, Brazil. Methods: The sample consisted of 60 medical records of patients admitted at the hospital. The records were analyzed according to the presence or absence of interactions between drugs and foods/nutrients of the prescribed diets. Results: Of the 82 drugs prescribed in all periods, there were 16 drugs (19.5%) with possible interaction with food, a total of 60 interactions between nutrient/food and medicine. Thus, 18 (30%), 10 (17%) and 8 (13%) possible interactions were identified with captopril (cardiovascular drug) with acetylsalicylic acid (anti-inflammatory) and spironolactone (diuretic), respectively representing the highest numbers of interactions among the classes of investigated drugs. It was also found that the total interactions between food/nutrients and drugs, 32 (53%) accounted for interactions with cardiovascular drugs, 13 (22%) with anti-inflammatory drugs, 11 (18%) with diuretic agents e 4 (7%) with drugs that act on the digestive tract. Conclusion: There was a high number of interactions between food/nutrients and medicines emphasizing the need for prior knowledge of these interactions as a way to avoid impairment in the treatment, longer hospital stays and/or damage to the nutritional status of the patients.
Objetivos: Avaliar as possíveis interações entre os medicamentos e os alimentos/nutrientes das dietas de pacientes do Hospital Regional Justino Luz do município de Picos, Piauí. Métodos: A amostra foi constituída por 60 prontuários médicos de pacientes internados analisados para verificar a presença ou não de interações entre os medicamentos e os alimentos/nutrientes das dietas prescritas. Resultados: Dos 82 medicamentos prescritos, em todos os períodos, havia 16 (19,5%) com possível interação com a alimentação, totalizando 60 interações entre nutriente/alimentos e medicamentos. Assim, foram identificadas 18 (30%), 10 (17%) e 8 (13%) possíveis interações com o captopril (droga cardiovascular), com o ácido acetilsalicílico (anti-inflamatório) e com a espironolactona (diurético), respectivamente, representando as maiores frequências de interações entre as classes farmacológicas investigadas. Detectou-se também que, do total das interações entre alimentos/nutrientes e medicamentos, 32 (53%) corresponderam a interações com drogas cardiovasculares; 13 (22%) com fármacos anti-inflamatórios, 11 (18%) com agentes diuréticos e 4 (7%) com fármacos que atuam sobre o trato digestório. Conclusão: Verificou-se um alto número de interações entre alimentos/nutrientes e medicamentos, reforçando a necessidade do conhecimento prévio dessas interações para que não haja prejuízo no tratamento, aumento do tempo de internação e/ou danos ao estado nutricional dos pacientes.
ABSTRACT
Embora a importância das interações medicamento-nutriente seja reconhecida, a abordagem sistemática para prevenção e monitorização destas interações como parte integrante da terapêutica, permitindo uma melhor predição das respostas clínicas, ainda é deficitária. O manejo inapropriado de algumas interações pode desencadear falha na terapêutica ou severos efeitos adversos ao paciente. A maior parte das interações envolve mudanças na biodisponibilidade oral e absorção, embora outros mecanismos também sejam sugeridos. Fatores que influenciam a interação medicamento-nutriente podem estar ligados ao hospedeiro, ao medicamento ou ao próprio nutriente. A maior parte das interações do tipo 1 podem ser evitadas, evitando-se a mistura do nutriente e o fármaco na mesma infusão. Enquanto algumas interações do tipo 2 podem ser evitadas separando-se o tempo de administração do medicamento e o nutriente, a maior parte das interações do tipo 2, envolvendo metabolismo e transporte, não pode ser evitada pela separação temporal da administração da alimentação e do medicamento. As interações relacionadas à nutrição enteral, indicam a recomendação de não administração de medicamentos diretamente na formulação enteral; não administração via sonda para nutrição, durante a nutrição enteral e a interrupção da mesma por duas horas antes e depois da administração de medicamentos. Princípios gerais para o manejo clínico e prevenção das interações medicamento-nutriente que poderão contribuir para implementar e facilitar a prática clínica, envolvem a identificação das consequências clínicas no curto e longo prazo, tais como sintomas clínicos e modificações de valores laboratoriais como resultado da interação, a consideração da necessidade de ajustes para doses de medicamentos ou suplementação nutricional e, considerações sobre a viabilidade de tratamento alternativo.
Although the importance of drug-nutrient interactions is recognized, a systematic approach to prevention and monitoring of these interactions as part of therapy, allowing better prediction of clinical response is poor. The inappropriate management of some interactions may trigger therapeutic failure or severe adverse effects to the patient. Most interactions involve changes in oral bioavailability and absorption, although other mechanisms are also suggested. Factors that influence drug-nutrient interaction may be linked to the host, the drug itself or the nutrient. Most of the interactions of type 1 can be prevented by avoiding the mixture of the same nutrient and drug infusion. While some interactions of type 2 can be avoided by separating the time of drug administration and the nutrient, most of the interactions of type 2, involving metabolism and transport, can not be avoided by temporal separation of the administration of food and medicine. The interactions related to enteral nutrition, indicate the recommendation of no drug administration directly into the enteral formula, not via the administration tube for nutrition, enteral feeding and during the same interrupt for two hours before and after drug administration. General principles for clinical management and prevention of drug-nutrient interactions that may contribute to implement and facilitate clinical practice, involving the identification of clinical consequences in the short and long term, such as clinical symptoms and changes in laboratory values as a result of the interaction, consideration of the need for adjustments to doses of medication or nutritional supplementation, and considerations about the feasibility of alternative treatment.
A pesar de la importancia de las interacciones fármaco-nutriente se reconoce, un enfoque sistemático para la prevención y el control de estas interacciones como parte del tratamiento, lo que permite una mejor predicción de la respuesta clínica es pobre. El manejo inadecuado de algunas interacciones pueden provocar fracaso terapéutico o efectos adversos graves para el paciente. La mayoría de las interacciones implican cambios en la biodisponibilidad oral y la absorción, aunque otros mecanismos también se sugirió. Factores que influyen en la interacción fármaco-nutrientes pueden ser vinculados a la acogida, la propia droga o de nutrientes. La mayoría de las interacciones de tipo 1 puede prevenirse si se evita la mezcla de los mismos nutrientes y la infusión de drogas. Mientras que algunas interacciones de tipo 2 se pueden evitar mediante la separación de la época de la administración de fármacos y nutrientes, la mayoría de las interacciones de tipo 2, del metabolismo y el transporte, no se puede evitar mediante una separación temporal de la administración de alimentos y medicinas. Las interacciones relacionadas con la nutrición enteral, indica la recomendación de no administración de la droga directamente en la fórmula de nutrición enteral, no a través del tubo de la administración de la nutrición, la alimentación enteral y durante la misma interrupción durante dos horas antes y después de la administración de drogas. Principios generales para la gestión clínica y la prevención de las interacciones entre medicamentos y nutrientes que pueden contribuir a poner en práctica y facilitar la práctica clínica, que incluirá la identificación de las consecuencias clínicas a corto y largo plazo, tales como los síntomas clínicos y los cambios en...
Subject(s)
Humans , Biochemical Phenomena , Food-Drug Interactions , Metabolism , Enteral NutritionABSTRACT
A inflamação é a resposta protetora do organismo contra uma lesão celular. O mastócito representa uma célula do tecido conjuntivo responsável pelo início da reação inflamatória e cronificação do processo. O objetivo deste estudo foi analisar possíveis modificações na população de mastócitos de ratos com colite experimental alimentados com diferentes emulsões lipídicas. Quarenta ratos Wistar, divididos em 4 grupos (controle e experimentais) recebendo dieta oral com óleo de linhaça (AGn-3), óleo de soja (AGn-6) e óleo de canola (AGn-9) untados na ração 20 dias antes da indução da colite com ácido acético a 10%. Cada grupo foi, então, subdividido em dois subgrupos de cinco animais e avaliada resposta inflamatória aguda e crônica. Apesar de o número médio de mastócitos não apresentar diferença estatisticamente significante entre os grupos (p>0,05), a redução no número médio dessas células nos grupos AGn-3 e AGn-9 é clinicamente relevante. Este trabalho e a literatura pertinente levantam a possibilidade de obter-se modulação mais efetiva da inflamação com emulsões lipídicas suplementadas com AGn-3 e AGn-9.
Inflammation is the body's protective response against cell damage. The mast cell is a connective tissue cell responsible for initiating the chronic inflammatory reaction and the process. The aim of this study was to examine possible changes in the population of mast cells in rats with experimental colitis fed different lipid emulsions. Forty Wistar rats were divided into four groups (control and experimental) received an oral diet with linseed oil (GNA-3), soybean oil (AGN-6) and canola oil (AGN-9) smeared in feed 20 days before the colitis induction with acetic acid to 10%. Each group was then subdivided into two subgroups of five animals and evaluated the acute and chronic inflammatory response. Although the average number of mast cells did not show a statistically significant difference between groups (p> 0.05), the reduction in the average number of these cells in groups AGN and AGN-3-9 is clinically relevant. This study and literature raise the possibility of obtaining more effective modulation of inflammation with lipid emulsions supplemented with AGN and AGN-3-9.
La inflamación es la respuesta de protección del cuerpo contra el daño celular. La célula del mástil es una célula del tejido conjuntivo responsable de iniciar la reacción inflamatoria crónica y el proceso. El objetivo de este estudio fue examinar los posibles cambios en la población de mastocitos en ratas con colitis experimental alimentado con diferentes emulsiones de lípidos. Cuarenta ratas Wistar se dividieron en cuatro grupos (control y experimental) recibió una dieta oral con aceite de linaza (GNA-3), aceite de soja (AGN-6) y el aceite de canola (AGN-9) untado en la alimentación de 20 días antes de la colitis inducción con ácido acético al 10%. Cada grupo se dividió luego en dos subgrupos de cinco animales y evaluar la respuesta inflamatoria aguda y crónica. La mediana del número de mastocitos no mostraron una diferencia estadísticamente significativa entre los grupos (p> 0,05), la reducción en el número promedio de estas células en los grupos de AGN y AGN-3 9-es clínicamente relevante. Este estudio y la literatura plantean la posibilidad de obtener la modulación más eficaz de la inflamación con emulsiones de lípidos suplementados con AGN y AGN-3-9.
Subject(s)
Animals , Fatty Acids/analysis , Fatty Acids , Colitis, Ulcerative/diet therapy , Eating , Metabolism/physiologyABSTRACT
PURPOSE: We investigated the biochemical characteristics of serum and urine in the patients suffering with uric acid stone. MATERIALS AND METHODS: A total of 99 patients suffering with uric acid stone underwent routine urine analysis and 24-hour urine analysis for determining the urinary calculi risk factors. We conducted serum analysis for the stone risk factors and also analysis of the stone analysis. To compare the stone risk factors, 93 patients with calcium stone were identified and then the biochemical risk factors in the serum and urine were evaluated. RESULTS: The mean age of patients with uric acid stone was 56.5+/-12.4 years and the mean age of the patients with calcium stone was 40.2+/-11.5 years. Serum uric acid, cholesterol and triglyceride were all significantly increased in the patients with uric acid stone compared to that in the patients with calcium stone. The patients with uric acid stone showed a lower urinary pH and also lower urinary uric acid and citric acid excretion compared with those patients with calcium stone. The composition of the uric acid stone was mixed with calcium in 63.6 percent of the stones and 36.4% of the stones were pure. CONCLUSIONS: The patients with uric acid stone had higher serum uric acid, cholesterol and triglyceride, and they had a lower urinary pH and lower uric acid and citric acid excretion as compared with the patients with calcium stone. Uric acid-calcium mixed stone was most common in the patients with uric acid stone. There is a great likelihood of uric acid stone in the patients with stone who have one or more of the above mentioned biochemical characteristics. Therefore, these factors are important to conduct metabolic evaluation for preventing stone recurrence.